Literature DB >> 11495698

Yolk-sac hematopoiesis: the first blood cells of mouse and man.

J Palis1, M C Yoder.   

Abstract

OBJECTIVE: To review the process of blood-cell formation in the murine and human yolk sac. DATA SOURCES: Most articles were selected from the PubMed database. DATA SYNTHESIS: The yolk sac is the first site of blood-cell production during murine and human ontogeny. Primitive erythroid cells originate in the yolk sac and complete their maturation, including enucleation, in the bloodstream. Though species differences exist, the pattern of hematopoietic progenitor cell emergence in the yolk sac is similar in mouse and man. In both species, there is a stage of development where both primitive red blood cells and definitive erythroid progenitors are produced in the yolk sac. An "embryonic" hematopoietic stem cell that engrafts in myeloablated newborn but not adult mice can be detected in the murine yolk sac and embryo. Stem-cell activity in the human yolk sac has not been reported.
CONCLUSIONS: The yolk sac is the sole site of embryonic erythropoiesis. However, definitive erythroid, myeloid, and multipotential progenitors also originate in the yolk sac. The relationship between these progenitors and the "embryonic" hematopoietic stem cell has not been elucidated. Yolk sac-derived progenitor cells may seed the developing liver via the circulation and serve as the immediate source of the mature blood cells that are required to meet the metabolic needs of the rapidly growing fetus.

Entities:  

Mesh:

Year:  2001        PMID: 11495698     DOI: 10.1016/s0301-472x(01)00669-5

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  103 in total

Review 1.  In search of "stemness".

Authors:  Jingli Cai; Mark L Weiss; Mahendra S Rao
Journal:  Exp Hematol       Date:  2004-07       Impact factor: 3.084

2.  Angiomyeloproliferative lesions following autologous stem cell therapy.

Authors:  Duangpen Thirabanjasak; Kavirach Tantiwongse; Paul Scott Thorner
Journal:  J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 10.121

3.  GATA-1 utilizes Ikaros and polycomb repressive complex 2 to suppress Hes1 and to promote erythropoiesis.

Authors:  Julie Ross; Lionel Mavoungou; Emery H Bresnick; Eric Milot
Journal:  Mol Cell Biol       Date:  2012-07-09       Impact factor: 4.272

Review 4.  B-1 B cell development in the fetus and adult.

Authors:  Encarnacion Montecino-Rodriguez; Kenneth Dorshkind
Journal:  Immunity       Date:  2012-01-27       Impact factor: 31.745

5.  Maturation and enucleation of primitive erythroblasts during mouse embryogenesis is accompanied by changes in cell-surface antigen expression.

Authors:  Stuart T Fraser; Joan Isern; Margaret H Baron
Journal:  Blood       Date:  2006-08-29       Impact factor: 22.113

6.  Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures.

Authors:  Marion Kennedy; Sunita L D'Souza; Macarena Lynch-Kattman; Staci Schwantz; Gordon Keller
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

Review 7.  Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis.

Authors:  Gregor Prindull
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

8.  CpG hypomethylation in a large domain encompassing the embryonic beta-like globin genes in primitive erythrocytes.

Authors:  Mei Hsu; Rodwell Mabaera; Christopher H Lowrey; David I K Martin; Steven Fiering
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

9.  New morphological aspects of blood islands formation in the embryonic mouse hearts.

Authors:  Anna Ratajska; Elzbieta Czarnowska; Agnieszka Kołodzińska; Anna Jabłońska; Emilia Stachurska
Journal:  Histochem Cell Biol       Date:  2008-11-27       Impact factor: 4.304

10.  A requirement for Notch1 distinguishes 2 phases of definitive hematopoiesis during development.

Authors:  Brandon K Hadland; Stacey S Huppert; Jyotshnabala Kanungo; Yingzi Xue; Rulang Jiang; Thomas Gridley; Ronald A Conlon; Alec M Cheng; Raphael Kopan; Gregory D Longmore
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.